BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38582283)

  • 1. Innovative Pharmaceutical Techniques for Paediatric Dosage Forms: A Systematic Review on 3D Printing, Prilling/Vibration and Microfluidic Platform.
    Racaniello GF; Silvestri T; Pistone M; D'Amico V; Arduino I; Denora N; Lopedota AA
    J Pharm Sci; 2024 Jul; 113(7):1726-1748. PubMed ID: 38582283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of three-dimensional printing for pediatric oral solid dosage forms.
    Kreft K; Fanous M; Möckel V
    Acta Pharm; 2024 Jun; 74(2):229-248. PubMed ID: 38815205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality control evaluation of paediatric chocolate-based dosage forms: 3D printing vs mold-casting method.
    Chachlioutaki K; Karavasili C; Mavrokefalou EE; Gioumouxouzis CI; Ritzoulis C; Fatouros DG
    Int J Pharm; 2022 Aug; 624():121991. PubMed ID: 35809833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3D printing in the design of pharmaceutical dosage forms.
    Souto EB; Campos JC; Filho SC; Teixeira MC; Martins-Gomes C; Zielinska A; Carbone C; Silva AM
    Pharm Dev Technol; 2019 Oct; 24(8):1044-1053. PubMed ID: 31180272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of 3D Printed Dosage Forms: Opportunities and Challenges.
    Alhnan MA; Okwuosa TC; Sadia M; Wan KW; Ahmed W; Arafat B
    Pharm Res; 2016 Aug; 33(8):1817-32. PubMed ID: 27194002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical aspects of printed oral dosage forms.
    Edinger M; Jacobsen J; Bar-Shalom D; Rantanen J; Genina N
    Int J Pharm; 2018 Dec; 553(1-2):97-108. PubMed ID: 30316794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of drug product development.
    Narayan P
    Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to Modify Drug Release in Paediatric Dosage Forms? Novel Technologies and Modern Approaches with Regard to Children's Population.
    Trofimiuk M; Wasilewska K; Winnicka K
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taste-masking methods in multiparticulate dosage forms with a focus on poorly soluble drugs.
    Simšič T; Planinšek O; Baumgartner A
    Acta Pharm; 2024 Jun; 74(2):177-199. PubMed ID: 38815202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-Dimensional (3D)-Printed Zero-Order Released Platform: a Novel Method of Personalized Dosage Form Design and Manufacturing.
    Fang D; Yang Y; Cui M; Pan H; Wang L; Li P; Wu W; Qiao S; Pan W
    AAPS PharmSciTech; 2021 Jan; 22(1):37. PubMed ID: 33409925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3D printed drug delivery devices: perspectives and technical challenges.
    Palo M; Holländer J; Suominen J; Yliruusi J; Sandler N
    Expert Rev Med Devices; 2017 Sep; 14(9):685-696. PubMed ID: 28774216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Printed Drug-Delivery Systems for Improved Patient Treatment.
    Sandler N; Preis M
    Trends Pharmacol Sci; 2016 Dec; 37(12):1070-1080. PubMed ID: 27992318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy for the individual: Towards patient integration into the manufacturing and provision of pharmaceuticals.
    Govender R; Abrahmsén-Alami S; Larsson A; Folestad S
    Eur J Pharm Biopharm; 2020 Apr; 149():58-76. PubMed ID: 31982577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent landscape of pediatric-friendly oral dosage forms and administration devices.
    Karavasili C; Gkaragkounis A; Fatouros DG
    Expert Opin Ther Pat; 2021 Jul; 31(7):663-686. PubMed ID: 33605825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional printing technology as a promising tool in bioavailability enhancement of poorly water-soluble molecules: A review.
    Jennotte O; Koch N; Lechanteur A; Evrard B
    Int J Pharm; 2020 Apr; 580():119200. PubMed ID: 32156531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional drug printing: a structured review.
    Ursan ID; Chiu L; Pierce A
    J Am Pharm Assoc (2003); 2013; 53(2):136-44. PubMed ID: 23571620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D floating tablets: Appropriate 3D design from the perspective of different in vitro dissolution testing methodologies.
    Ilyés K; Balogh A; Casian T; Igricz T; Borbás E; Démuth B; Vass P; Menyhárt L; Kovács NK; Marosi G; Tomuță I; Nagy ZK
    Int J Pharm; 2019 Aug; 567():118433. PubMed ID: 31201932
    [No Abstract]   [Full Text] [Related]  

  • 18. Modified release kinetics in dual filament 3D printed individualized oral dosage forms.
    Tidau M; Finke JH
    Eur J Pharm Sci; 2022 Aug; 175():106221. PubMed ID: 35662635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives on 3D printed personalized medicines for pediatrics.
    Tong H; Zhang J; Ma J; Zhang J
    Int J Pharm; 2024 Mar; 653():123867. PubMed ID: 38310991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D Printing of Solid Oral Dosage Forms: Numerous Challenges With Unique Opportunities.
    Okafor-Muo OL; Hassanin H; Kayyali R; ElShaer A
    J Pharm Sci; 2020 Dec; 109(12):3535-3550. PubMed ID: 32976900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.